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Neuropathic pain is associatedwith hyperexcitability and intrinsic ﬁring of dorsal root ganglia
(DRG) neurons. These phenotypical changes can be long lasting, potentially spanning the
entire life of animal models, and depend on altered expression of numerous proteins,
including many ion channels. Yet, how DRGs maintain long-term changes in protein
expression in neuropathic conditions remains unclear. DNA methylation is a well-known
mechanism of epigenetic control of gene expression and is achieved by the action of three
enzymes: DNA methyltransferase (DNMT) 1, 3a, and 3b, which have been studied primarily
during development.We ﬁrst performed immunohistochemical analysis to assess whether
these enzymes are expressed in adult rat DRGs (L4–5) and found that DNMT1 is expressed
in both glia and neurons, DNMT3a is preferentially expressed in glia and DNMT3b is
preferentially expressed in neurons. A rat model of neuropathic pain was then used to
determine whether nerve injury may induce epigenetic changes in DRGs at multiple time
points after pain onset. Real-time RT PCR analysis revealed robust and time-dependent
changes in DNMT transcript expression in ipsilateral DRGs from spared nerve injury (SNI)
but not sham rats. Interestingly, DNMT3b transcript showed a robust upregulation that
appeared already 1 week after surgery and persisted at 4 weeks (our endpoint); in contrast,
DNMT1 and DNMT3a transcripts showed only moderate upregulation that was transient
and did not appear until the second week.We suggest that DNMT regulation in adult DRGs
may be a contributor to the pain phenotype and merits further study.
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INTRODUCTION
Neuronal cell bodies located in the dorsal root ganglia (DRGs) gen-
erate the ﬁbers that convey information from the skin,muscles and
joints to the spinal cord (Gardner et al., 2000). This information
includes signals mediated by activation of nociceptors (Ringkamp
and Meyer, 2009). Nociceptive ﬁbers can be myelinated A ﬁbers,
originating from large DRG neurons, or unmyelinated C ﬁbers
originating from small and medium DRG neurons.
In normal conditions nociceptors have a high ﬁring threshold,
and these neurons do not ﬁre action potentials in the absence
of noxious inputs. Only when the innervated organs are exposed
to noxious stimuli are action potentials generated in the periph-
eral axonal endings. In the presence of nerve injury or chronic
pain, however, nociceptors become intrinsically ﬁring and their
intrinsic ﬁring frequency correlates with spontaneous pain (Weng
et al., 2012); moreover, DRG neurons become capable of ectopic
(somatic) ﬁring and this is also considered a cause of neuro-
pathic pain (Nordin et al., 1984; Sukhotinsky et al., 2004). These
changes are often indicated as peripheral sensitization and they
are not restricted to the injured nerve ﬁbers but often include
adjacent neurons, which may also generate spontaneous ﬁring
(Michaelis et al., 1996). These aberrant electrophysiological phe-
notypes are the consequence of large changes in ion channel gene
expression and distribution (Novakovic et al., 1998; Tanaka et al.,
1998; Dib-Hajj et al., 1999; Tan et al., 2006; Xiang et al., 2008; Fan
et al., 2011; Weng et al., 2012).
Changes in ion channel expression are well documented and
may explain the increased electrical excitability of DRG neu-
rons, yet, one of the key issues that remain unaddressed concerns
the mechanisms responsible for maintaining this altered gene
expression that contributes to the chroniﬁcation of pain. DNA
methylation represents one of the most widely used mechanisms
of enduring cellular memory and recently it was shown to medi-
ate transient changes in gene expression in the hippocampus as
well as long term changes in the cortex that occur during mem-
ory processes such as contextual fear conditioning (Miller and
Sweatt, 2007; Miller et al., 2010). DNA methylation occurs on
CpG sites by the action of enzymes known as DNA methyltrans-
ferases (DNMTs). Methylation is implicated in X chromosome
inactivation (Wolf et al., 1984; Gendrel et al., 2012; Dupont and
Gribnau, 2013) and is associated with gene silencing in general
(Wolffe and Matzke, 1999), most likely by attracting methylation-
speciﬁc transcriptional inhibitors. In DNA from mammalian
somatic tissues ∼70% of all CpG sites are methylated (Ehrlich,
2003). It is widely believed that active demethylation also takes
place (Bruniquel and Schwartz, 2003; Barreto et al., 2007; Ooi
and Bestor, 2008; Kaas et al., 2013), although no demethylase
has been isolated so far. 5 DNMTs have been identiﬁed to date,
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although only DNMT1, DNMT3a, and DNMT3b possess cat-
alytic activity (Bestor et al., 1988; Okano et al., 1998; Chedin,
2011; Qin et al., 2011). Interestingly, while the developmental
importance of methylation was apparent from the start, its impor-
tance in the adult nervous system has been demonstrated only
recently; knockout of DNMT1 and DNMT3a in adult forebrain
neurons leads to several deﬁcits in neuronal plasticity (Feng et al.,
2010). An increasingly large number of papers are addressing the
role of DNMTs in cancer and, more recently, in early life expe-
riences (McGowan et al., 2009; Szyf and Bick, 2013), memory
processes (Miller and Sweatt, 2007; Miller et al., 2010), addic-
tion (LaPlant et al., 2010), and Schizophrenia (Grayson et al.,
2005; Veldic et al., 2005). However, little work has been done
thus far investigating the potential role of these enzymes in
pain.
Hints that epigenetic changes in the spinal cord may be
involved in pain chroniﬁcation have come from reports that
expression of DNMT’s is modulated in dorsal horn neurons
following inﬂammation or nerve injury (Tochiki et al., 2012)
and intrathecal spinal injection of a DNMT inhibitor improved
pain behavior in the chronic constriction injury (CCI) model
(Wang et al., 2011). Two recent reports of changes in histone
acetylation in DRGs of a mouse model of neuropathic pain
suggest that epigenetic mechanisms may also be important in
maintaining DRG phenotype (Uchida et al., 2010a,b). However,
no data are available concerning DNMT expression in adult
DRGs or its potential modulation by pain. Here we show that
DNMTs are expressed in adult DRGs and that expression of
isoform DNMT3b is upregulated almost fourfold after nerve
injury, while DNMT1 and DNMT3a are upregulated moderately
and only transiently. This suggests a potential role for changes
in DNA methylation in initiation and/or maintenance of the




All studies were approved by the Animal Care and Use Committee
of Northwestern University.
SPARED NERVE INJURY MODEL
Twenty to 21-day-old rats were anesthetized using gas anesthe-
sia (isoﬂurane 1–2%, 30% N2O, and 70% O2). For induction of
spared nerve injury (SNI)-neuropathy, the sciatic nerve of the left
paw was exposed at the level of the trifurcation into the sural,
tibial, and common peroneal nerves. The tibial and common per-
oneal nerves were tightly ligated and severed, leaving the sural
nerve intact (Decosterd and Woolf, 2000). A second group of ani-
mals was used for control sham surgery. In this case, the left sciatic
nerve was exposed just as in the SNI procedure but was not further
manipulated.
BEHAVIORAL TEST FOR TACTILE SENSITIVITY
Tactile sensitivity of the spared region of the operated paws was
measured from the withdrawal responses to mechanical stimu-
lation with von Frey ﬁlaments. Animals were placed in a cage
with wire grid ﬂoor and allowed to habituate to the environment
for 15 min. Filaments (Stoelting) of varying forces were applied
to the plantar surface of the hind paw in ascending order. Each
ﬁlament was applied for a maximum of 10 s. Paw withdrawal
during the application was considered a positive response. 50%
response thresholds were calculated according to (Chaplan et al.,
1994). All animals that underwent SNI surgery developed tac-
tile allodynia in the left paw that persisted until they were
sacriﬁced.
RT-PCR ANALYSIS
L4 and L5 DRGs were dissected from sham operated and SNI rats;
DRGs both ipsilateral and contralateral to the injury were col-
lected 1, 2, and 4 weeks after onset of SNI injury and frozen in
liquid nitrogen and stored at −80◦C. RNA was extracted using a
Qiagen RNeasy RNA extraction kit that includes a column that
binds DNA while allowing RNA to ﬂow through in order to pre-
vent DNA contamination. Sufﬁcient RNA quantity and purity for
each sample was veriﬁed by RNA Nanodrop measurements. RNA
was then reverse transcribed into cDNA using Roche’s First Strand
cDNA Synthesis kit and oligo dT primers. Quantitative RT-PCR
was performed using a Roche Lightcycler 480 (LC480) with Roche
probes or SYBR green master mix, primers (0.4 μM), and DRG
cDNA. All PCR reactions were run using a 5 min hot start at
95◦C, followed by 45 cycles of 10 s at 95◦C, 15 s at 60◦C, and 10 s
at 72◦C. All samples were run in duplicate. Gel electrophoresis
(1.8% agarose) demonstrated a single band for ampliﬁcation tar-
gets. Although all primers were intron spanning, cDNA negative
and reverse transcriptase negative controls were done for genes
of interest and were negative. GAPDH was used as the reference
gene and all genes of interest were normalized to it. As recom-
mended in the MIQE qRT-PCR guidelines, β actin transcript was
quantiﬁed relative to GAPDH (data not shown) to validate the
stability of GAPDH as a reference gene (Bustin et al., 2010). Stan-
dard curves were also done to calculate reaction efﬁciency for
each gene product using dilutions of cDNA. All data were efﬁ-
ciency corrected using Roche LC480 software and the delta delta
Ct method (Schmittgen and Livak, 2008). For the gene expres-
sion analysis 1, 2, and 4 weeks post surgery n = 8, 4, and 6
SNI/sham pairs, respectively. All primers and efﬁciencies are listed
in Table 1.
For the experiment determining relative abundance of DNMT’s
in DRGs 5 naïve rats aged 4 weeks were used. L4 and L5 DRGs were
dissected, frozen in liquid nitrogen and transcript levels quantiﬁed
via qRT-PCR with CYBR green master mix as described above. As
there was no signiﬁcant difference in DNMT expression on the left
or right side of the rats, data from the right and left DRGs from
each rat were pooled and relative abundance determined.
IMMUNOHISTOCHEMISTRY
Five to seven week-old naïve or SNI male Sprague Dawley rats
were anesthetized using ketamine/xylazine (80 and 10 mg/0.1 kg,
respectively) and perfused transcardially with saline and then with
4% paraformaldehyde. L4 and L5 dorsal DRGs were dissected
out and post ﬁxed in paraformaldehyde for 1 h after which they
were cryoprotected with 10% sucrose overnight followed by 20%
sucrose. DRGs were then embedded in OCT, frozen on dry ice,
and cut into 20 μm slices using a Microtome Cryostat HM 505E.
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Table 1 | Primer sequences, efficiencies, slopes, and Roche probes used for genes of interest.
Gene Primers Efficiency Slope Roche probe and product #
DNMT1 L ccatcacgtctcacttcaagg R tgcgtttcttatcctggtctc 1.99 −3.36 NA-CYBR green
DNMT3a L ctgatgacgagcccgagtat R ctgtcatccaccaagacacaa 1.96 −3.44 NA-CYBR green
DNMT3b L gatgatcgacgccatcaag R cgagcttatcattctttgaagcta 1.98 −3.37 8404689089001
GAPDH L ctgcaccaccaactgcttag R tgatggcatggactgtgg 2.00 −3.32 Rat GAPDH Ref 05046220001
Beta actin L aaggccaaccgtgaaaagat R accagaggcatacagggaca 1.91 −3.56 NA-CYBR Green
Sections were incubated at 40◦C for 15 min prior to staining
and then incubated for 36 h in primary antibody in TBS with
0.2% triton-X and 3% NGS. Sections were then washed with
TBS and incubated for 2 h at 22–24◦C in secondary antibod-
ies in TBS. Sections were again washed (6–8 times) in TBS with
one ﬁnal wash in PBS. Sections were mounted and imaged on
a Zeiss UV LSM 510 META confocal microscope. Z-stacks (8–
12 in 2 micron steps) were taken for all image analyses. Primary
antibodies were DNMT1 (Santa Cruz #20701; Sharif et al., 2007;
Metivier et al., 2008; DNMT3a, Santa Cruz #20703; Ooi et al.,
2010; Zhang et al., 2011a; Zhu et al., 2012; DNMT3b, Santa Cruz
#20704; Di Giaimo et al., 2005; Zhang et al., 2011a). Secondary
antibody was Invitrogen Goat anti-Rabbit 488. Controls including
primary antibody alone and secondary antibody alone were nega-
tive. Additionally, speciﬁcity forDNMT1andDNMT3a antibodies
was veriﬁed using western blot (WB) analysis. The DNMT3b anti-
body did not give a detectable signal in WB, most likely because
of the very low expression level of this molecule in adult DRG
tissue.
STATISTICAL ANALYSIS
Statistical signiﬁcance of differences in expression data was deter-
mined at the 0.05 level using Analysis of Variance with post hoc
correction (Student-Newman-Keuls). Data from sham left and
right DRG were pooled and used for comparison with contra- and
ipsi-lateral SNI. The “sham” expression level in the ﬁgures rep-
resents these pooled data. All data in the paper are presented as
average ± standard error of the mean (SEM). Error bars in ﬁgures
also represent SEM.
RESULTS
DNMT1 EXPRESSION IS ROBUST AND WIDESPREAD IN ADULT DRGs
Immunochemical analysis was performed on 20 μm-thick slices
obtained from L4 and L5 DRGs of 5–7 week old naïve rats to
study the expression of the DNMT1, DNMT3a, and DNMT3b
in L4 and L5 DRGs of adult rats. Immunostaining of DNMT1
demonstrated that expression is robust and is detected ubiq-
uitously in the nuclei of DRG neurons as well as in Schwann
cells (Figure 1). Indeed labeling with the nuclear dye 4′,6-
diamidino-2-phenylindole (DAPI) revealed almost perfect over-
lap with DNMT1 expression in both DRG neuronal nuclei
(Figures 1A–C, see arrowheads for examples) and the nuclei
of Schwann cells surrounding DRG axons (Figures 1D–F).
Interestingly, DNMT1 expression was not detected in the satellite
cells that surround and support DRG neuronal cell bodies
(Figures 1A–C).
DNMT3a EXPRESSION IS FOUND IN GLIA OF ADULT DRGs
In contrast to DNMT1 staining in nuclei of DRG neurons,
immunostaining L4 and L5 DRG sections for DNMT3a revealed
robust expression in the nuclei of supporting satellite glia
(Figures 1G–I). In additionDNMT3awas detected in the nuclei of
many Schwann cells (Figures 1J–L). Thus, surprisingly, DNMT3a
was not detected in nuclei of DRG neurons (Figures 1G–I).
DNMT3b EXPRESSION IS LIMITED TO DRG NEURONS
Labeling of L4 and L5 DRG sections for DNMT3b demon-
strated expression of DNMT3b in nuclei of all DRG neurons
(Figures 1M–O). Notably, no overlap was detected for DNMT3b
and DAPI in axons, suggesting that DNMT3b expression is
selective for neurons and is absent in glia (Figures 1P–R).
RELATIVE ABUNDANCE OF DNA METHYLTRANSFERASE TRANSCRIPT
IN DRGs IN NAIVE RATS
As no data are available concerning DNMT expression in rat DRG,
we next quantiﬁed the relative abundance of DNMTs in L4 and L5
DRGs from naive rats. One month old rats were used to per-
form qRT-PCR measurements of DNMT transcript. qRT-PCR
data was efﬁciency corrected, normalized to the GAPDH refer-
ence gene, and expression levels compared. PCR products were
ﬁrst run on a gel to demonstrate primer accuracy and conﬁrmed a
single band for each reaction (Figure 2A). DNMT1 and DNMT3a
had much higher transcript levels than DNMT3b (Figure 2B).
This is consistent with immunocytochemistry data showing that
DNMT1 and DNMT3a staining was present in both neurons
and glia, while staining for DNMT3b was restricted to the neu-
ronal population (Figure 1). These experiments conﬁrmed that
DNMTs are expressed in rat DRG at the level of both mRNA and
protein.
UPREGULATION OF DNMT’s IN THE SNI MODEL OF NEUROPATHIC PAIN
Having found that all DNMTs are expressed in the adult DRG,
although in a cell-type dependent pattern, we wondered whether
their expression levels are affected following neuropathic injury.
Widespread changes in gene expression have been reported in
animal models of neuropathic pain, and it is possible epigenetic
mechanisms may underlie at least some of these changes. To test
this hypothesis we took advantage of the SNI model, a robust and
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FIGURE 1 | DNA methyltransferase expression in DRG is cell-type
specific. 20-micron L4 and L5 DRG sections from control rats aged
5–7 weeks were immuno-labeled with DNMT antibodies as well as
incubated with the nuclear labeling dye 4’,6-diamidino-2-phenylindole (DAPI).
(A–C) Show robust and ubiquitous labeling of DNMT1 in nuclei of DRG
neurons. Notably, there is little expression of DNMT1 detected in the satellite
cells surrounding DRG neurons. In addition, widespread overlap of DAPI and
DNMT1 was detected in axons, demonstrating ubiquitous expression in
Schwann cells (D–F). (G–I) In contrast to DNMT1, DNMT3a was not detected
in neuronal nuclei but rather in satellite cells surrounding DRG neurons.
(J–L) DNMT3a also showed widespread overlap with DAPI in nuclei of
Schwann cells. (M–O) DNMT3b was detected in nuclei of all DRG neurons.
(P–R) Notably, DNMT3b staining did not reveal overlap with DAPI in DRG
axons, suggesting DNMT3b is not expressed in glia. Scale bar: 20 μM.
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FIGURE 2 | Relative abundance of DNMT transcripts in adult rat DRGs.
(A) PCR products run on a 1.8% agarose gel demonstrate a single
ampliﬁcation product for each gene of interest. DNMT3b and GAPDH were
run together as this assay involved multiplexing DNMT3b and GAPDH in
the same PCR well, thus the two bands in one lane. (B) Quantitative
RT-PCR was ﬁrst used to determine the relative abundance of DNMTs from
ﬁve naive rats at 1 month of age. All DNMT gene expression is normalized
to GAPDH. Note the higher expression levels of DNMT1 and DNMT3a
while DNMT3b is lower, consistent with immunocytochemistry data
(Figure 1). Note the plot is on a logarithmic scale.
well-established model of neuropathic pain, which involves sever-
ing the tibial and peroneal portions of the sciatic nerve (Decosterd
and Woolf, 2000). Tactile sensitivity was measured to verify the
efﬁcacy of the surgery. von-Frey ﬁlament testing was performed
on all SNI and sham operated rats prior to experimental use
and conﬁrmed the presence of allodynia in all SNI rats but not
sham controls. The left (operated) paw von Frey thresholds were
3.93 ± 0.58 g and 0.55 ± 0.41 g at 1 week, 5.16 ± 0.49 g and
0.64 ± 0.16 g at 2 weeks, and 7.93 ± 0.77 g and 0.97 ± 0.44 g at
4 weeks after surgery for sham-operated and SNI rats, respectively
(Figure 3). qRT-PCR experimentswere done 1, 2, and 4weeks post
surgery using L4 and L5 DRG tissue of control (sham operated)
and SNI rats; genes of interest were normalized to the GAPDH ref-
erence gene. All data are shown normalized to age matched sham
controls. First, the amount of beta actin transcript was quanti-
ﬁed relative to GAPDH for all SNI and sham groups to test the
stability of GAPDH and verify it’s suitability for use as a ref-
erence gene. No signiﬁcant changes were detected in beta actin
transcript levels between SNI and sham at 1, 2, or 4 weeks post
surgery, thus conﬁrming its suitability as a reference gene (data
not shown).
At 1 week post injury, qRT-PCR experiments for DNMT tran-
scripts demonstrated no signiﬁcant changes in expression levels
for both DNMT1 and DNMT3a transcripts, in the DRGs ipsi-
or contralateral to the injured nerve relative to sham controls
(Figure 4A). However, analysis of the DNMT3b transcript in the
DRG ipsilateral to the injured nerve revealed a signiﬁcant, almost
fourfold increase (p < 0.001) in expression levels relative to sham
(Figure 4A). DNMT3b expression was unchanged in the DRG
contralateral to nerve injury.
In order to better understand the changes occurring in DRG
neurons during more chronic conditions, DNMT transcript levels
were also measured at 2 and 4 weeks post surgery. Interest-
ingly, at 2 weeks post injury DNMT1 transcript was increased
by 38% (p < 0.05) relative to sham controls in the DRG
ipsilateral to nerve injury (Figure 4B). Also, DNMT3a tran-
script was increased by 58% (p < 0.05) relative to sham in
FIGURE 3 |Von Frey measurements in SNI and sham rats.The spared
nerve injury (SNI) model of neuropathic pain was used. The left or ipsilateral
nerve was injured while the right or contralateral nerve was intact. Tactile
sensitivity of the spared region of the operated paws was measured from
the withdrawal responses to mechanical stimulation with von Frey
ﬁlaments. 50% response thresholds were calculated according to Chaplan
et al. (1994). Data are shown by dividing the contralateral/right paw over the
ipsilateral/left paw, at 1, 2, and 4 weeks post SNI or sham surgery. All
animals that underwent SNI surgery developed signiﬁcant tactile allodynia
in the ipsilateral/left paw that persisted until they were sacriﬁced, while
sham rats showed no changes, *p < 0.01. n = 8 SNI and sham for 1 week,
4 for 2 weeks, and 6 for 4 weeks. The left foot von Frey thresholds for
sham-operated and SNI rats, respectively, were 3.93 ± 0.58 g and
0.55 ± 0.41 g at 1 week, 5.16 ± 0.49 g and 0.64 ± 0.16 g at 2 weeks, and
7.93 ± 0.77 g and 0.97 ± 0.44 g at 4 weeks after surgery.
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FIGURE 4 | Nerve injury induces a robust and long lasting
increase in DNMT3b expression. Gene expression is normalized to
GAPDH. All SNI data are normalized to sham controls. (A) At 1 week
post nerve injury, qRT-PCR experiments demonstrate a signiﬁcant,
almost fourfold increase in DNMT3b transcript in the DRG ipsilateral
to the injured nerve. DRGs contralateral to nerve injury showed no
signiﬁcant changes, *p < 0.001. n = 8 SNI and 8 sham. (B) At
2 weeks post nerve injury, qRT-PCR experiments demonstrate a
signiﬁcant increase in DNMT1 (38%), DNMT3a (58%), and DNMT3b
(twofold) transcripts in the DRGs ipsilateral to the injured nerve.
DRGs contralateral to nerve injury showed no changes, *p < 0.05.
n = 4 SNI and 4 sham animals. (C) At 4 weeks post nerve injury,
qRT-PCR experiments demonstrate a signiﬁcant, approximately 40%
increase in DNMT3b transcripts in the DRGs ipsilateral to the injured
nerve. DRGs contralateral to nerve injury showed no changes. For
DRGs ipsilateral to injury in SNI rats, DNMT1 showed a trend toward
being increased by 27% with p = 0.09 while DNMT3a also showed
a slight trend of being increased by 42% with p = 0.22, *p < 0.05.
n = 6 SNI and 6 sham.
the DRG ipsilateral to nerve injury. For both DNMT1 and
DNMT3a, no signiﬁcant changes were found in the DRG con-
tralateral to nerve lesion. In addition DNMT3b expression was
still increased more than twofold (p < 0.05) in the DRG ipsilat-
eral to nerve injury, with no change contralateral to the injury
(Figure 4B).
At 4 weeks post injury, in the ipsilateral DRG both DNMT1
and DNMT3a transcripts still showed a trend for a slight increase
relative to sham controls (28% for DNMT1, p = 0.09, 42%
for DNMT3a, p = 0.22); no signiﬁcant increase was found in
the DRG contralateral to nerve injury (Figure 4C). DNMT3b
transcript was still signiﬁcantly elevated by 41% in the DRG
ipsilateral to nerve injury (p < 0.05). DRGs contralateral to
injury showed no changes. Thus, these data demonstrate that
nerve injury associated changes in DNMT3b expression are early
and robust, while changes in DNMT1 and DNMT3a occur later
and more transiently. Thus, only DNMT3b transcript expres-
sion was signiﬁcantly increased at all time points after surgery.
Because, in control conditions, this transcript is found in all
neurons, but not in glia, we wanted to verify whether this qualita-
tive pattern is maintained after peripheral nerve injury. There-
fore, immunohistochemistry was performed on DRG sections
from 2 SNI animals 1 week after the surgery, when the tran-
script expression was the highest (Figure 5). We found that,
similar to the naïve rat condition, DNMT3b expression was
still neuronal-speciﬁc and no evidence for glial expression was
found.
DISCUSSION
DNA METHYLATION IN ADULT ANIMALS
While the role of DNMTs during development has been the focus
of intense study for many years (Lyko et al., 1999; Okano et al.,
1999; Ko et al., 2005), much less is known about their role in
the adult. However, an increasing amount of data supports a
critical role for DNA methylation in adult animals, and in the
brain in particular. For instance, changes in DNA methylation
have been linked to long-lasting alteration of local circuits, such
as those implicated in memory consolidation (Miller and Sweatt,
2007; Lubin et al., 2008). Furthermore, conditional knockdown
of DNMT1 and DNMT3a in adult mouse forebrain excitatory
neurons resulted in disruption of long term plasticity in area
CA1, including deﬁcits in learning and memory, and changes
in gene expression and DNA methylation (Feng et al., 2010).
This conﬁrmed the crucial role played by DNMTs in adult post-
mitotic neurons. Changes in DNMT gene expression as well as
DNA methylation have also been shown to take place in psy-
chiatric diseases such as schizophrenia (Tremolizzo et al., 2002;
Veldic et al., 2005). Observations have also been made that involve
other epigenetic mechanisms, such as histone acetylation that
has been shown to be implicated in numerous brain activi-
ties such as memory formation (Fischer et al., 2007; LaPlant
et al., 2010); and neurodegenerative diseases such as Hunting-
ton’s disease (Butler and Bates, 2006). Thus, strong evidence
supports a critical role for epigenetic regulation of CNS activ-
ity in adult animals. So far, however, no reports have identiﬁed
whether DNMT transcripts are expressed in adult DRGs and if
they may be affected in the setting of neuropathic pain. Here
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FIGURE 5 | DNMT3b transcript expression remains exclusively
neuronal after peripheral nerve injury. Immunohistochemisry was
performed on sections obtained from DRG ipsilateral to the peripheral
injury in two SNI rats 1 week post-surgery. (A,B) are two examples of
images obtained by staining the DRG sections with DNMT3b (green)
antibody and DAPI (blue). Note that, similar to the naïve tissue, DNMT3b
expression is ubiquitous in neurons, but absent from glia.
we used immunohistochemical analysis to identify expression
of DNMT1, 3a and 3b in adult rat DRG and show that all
three DNMTs are expressed, although at different levels and in
a cell-type dependent manner. We also demonstrate signiﬁcant
upregulation of DNMT’s in an animal model of neuropathic
pain.
DRG DNA METHYLATION AND PAIN
A major component of pain suffering in modern societies is
chronic in nature; yet, there is little understanding regarding the
mechanisms of pain chroniﬁcation and no scientiﬁcally validated
therapies for such conditions (Dworkin, 2002). DRGs are the ﬁrst
step in the pain pathway. Small and medium size DRG neurons
generate c- and Aβ and Aδ nociceptor ﬁbers. Animal as well as
human studies have recently shown that all major stations in the
pain pathway are affected in chronic pain conditions. In partic-
ular, pain-associated functional and/or morphological changes
have been described in DRG neurons (Devor and Wall, 1990;
Kajander et al., 1992; Jimenez-Andrade et al., 2006), spinal cord
(Coull et al., 2003; Braz et al., 2012) and several brain areas includ-
ing the amygdala (Neugebauer and Li, 2003; Neugebauer et al.,
2003; Bird et al., 2005), the anterior cingulate cortex (Li et al.,
2010), the hippocampus (Ren et al., 2011; Mutso et al., 2012)
and the prefrontal cortex (Metz et al., 2009; Baliki et al., 2010,
2012). Critical questions that remain unanswered concern the site
of origin for these changes and their temporal evolution. Epige-
netic mechanisms have been previously suggested to contribute
to the development of persistent pain. For instance, epigenetic
suppression of GAD65 expression in the nucleus raphe magnus
has been shown to favor the development of persistent inﬂam-
matory pain (following injection of complete Freund’s adjuvant;
Zhang et al., 2011b). In addition levels of DNMT’s were altered in
the spinal cord after nerve or inﬂammatory injury (Tochiki et al.,
2012). Also, intrathecal spinal injection of the DNMT inhibitor
5-azacytidine was shown to alleviate neuropathic pain in the CCI
model (Wang et al., 2011). Thus, we investigated the expression
level of DNMT transcripts in DRGs in the SNI model of neu-
ropathic pain. We found that the expression level of DNMT3b
transcript, which in adult DRGs is expressed in neurons but not
in glia, is dramatically increased at 1, 2, and 4 weeks after the
neuropathic lesion. In addition, DNMT1 and DNMT3a were
upregulated at 2 weeks post injury. This upregulation was at least
in part surprising because neuropathic pain is associated with
increased neuronal ﬁring and neuronal depolarization was previ-
ously reported to reduce DNMT expression (Sharma et al., 2008).
Therefore, the observed changes in DNMT expression may be
considered the result of a complex program rather than a direct
consequence of neuronal electrophysiological activity. Immuno-
histochemistry of SNI DRGs for DNMT3b revealed no detection
of DNMT3b in glia, suggesting that glial activation following SNI
surgery is not linked to DNMT3b expression, suggesting that the
increase occurs in neurons. Independent of the speciﬁc mech-
anisms, however, altered DNMT expression in DRGs may be
involved in the transition from acute to chronic pain and may
underlie some of the numerous changes in gene expression in
painmodels. Accordingly,microarray studies carried out onDRGs
from peripheral axotomy pain models have reported gene expres-
sion changes for several hundred genes (Costigan et al., 2002; Xiao
et al., 2002).
Epigenetic control of genes includes both histone modiﬁca-
tions and DNA methylation and regulates gene expression by
changing the accessibility of transcriptional machinery to the
DNA. Although there are some exceptions, DNA methylation
of gene promoters is generally associated with gene silencing
(Wolffe and Matzke, 1999). The upregulation of DNMT’s in
the DRG may result in a number of speciﬁc and/or broader
functional consequences. Considered broadly, one could expect
upregulation of DNMTs to largely result in suppression of gene
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expression. Also, as DNMT3a and DNMT3b are involved primar-
ily in de novo methylation (Okano et al., 1999), their upregulation
may lead to new patterns of DNA methylation in DRGs. We
show here robust upregulation of DNMT3b up to 4 weeks post
injury, however, as DNA methylation marks can be quite sta-
ble, even the transient upregulation of DNMT1 and DNMT3a
(at 2 weeks post injury) may contribute to long lasting changes in
gene expression. It is worth noting that DNMT’s can also repress
transcription independent of DNA methylation by recruiting the
chromatin remodeling enzymes histone deacetylases (HDAC’s).
DNMT1 can recruit HDAC 1 and HDAC 2 (Rountree et al.,
2000) while the DNMT3 family can interact with HDAC1 via a
different mechanism (Bachman et al., 2001). The upregulation
of DNMTs reported here is thus consistent with recent reports
of reduced histone acetylation at the promoter of several genes
in a mouse model of neuropathic pain (Uchida et al., 2010a,b)
and points to the possibility that inhibiting DNMT activity in
the DRG after nerve injury may serve to prevent some of the
pathological changes in gene expression and improve the pain
phenotype.
The observation that DNMT3b is most heavily regulated in the
pain condition is intriguing considering that, in keeping with our
ﬁnding in DRGs, DNMT3b is expressed at low levels in adult
tissue, except in thyroid, testis, and bone marrow (Xie et al.,
1999). Similar to our ﬁnding in the pain condition DNMT3a
and DNMT3b were shown to be upregulated in area CA1 of
the hippocampus after fear conditioning in rats, and DNMT
inhibitorswere shown to block learning andmemory. These obser-
vations support a function for DNMT3s in plastic mechanisms
in adult brain tissue (Miller and Sweatt, 2007). DRG in particu-
lar may undergo plastic changes both in pathological conditions
where nerve injury induces maladaptive responses in gene expres-
sion and neuronal excitability, and in physiological conditions
where nociceptors receive and integrate numerous inputs from
the periphery. Interestingly, DNMTs undergo alternative splicing
in a tissue and developmental stage speciﬁc pattern, and DNMT3b
has by far the most with some estimates of almost 40 splice vari-
ants (Okano et al., 1998; Wang et al., 2006a,b; Ostler et al., 2007;
Gopalakrishnan et al., 2009; Gordon et al., 2013). It is possible that
one of these developmental variants may be upregulated in the
DRG following the SNI injury although future studies will be
required to examine this more closely.
Finally, it is important to stress that neither the effect of neuro-
pathic injury onDRGDNMTexpressionnor thepatternof DNMT
expression in adult DRGs were previously investigated. Thus, as
almost every study, and work addressing new ideas in particular,
this paper has also limitations. One such limitation is that the func-
tional consequences of the dysregulation in DNMT expression are
unclear. Methylation array data from SNI and sham DRGs may
help answer this question, but there are technical problems for
such a study. The major problem consists in the difﬁculty to sepa-
rate glia and neurons. Our data show that expression of DNMT3b,
which is the lowest in DRGs and is selective for neurons, is mostly
altered following neuropathic injury. The DRG contains far more
glial cells than neurons, thus methylation arrays from DRG tissue
would in reality provide more of a glial methylation signature than
neuronal. Considering that high cost of a global DNA methylation
analysis and this lack of cell speciﬁcity the cost to beneﬁt ratio does
not justify such an experiment at this moment although one may
imagine that in the near future cell-sorting capability may render
such analysis worthwhile.
ACKNOWLEDGMENTS
This work was supported by NIH grants: NS064091 (Marco
Martina) and DE022746 (A. V. Apkarian). Imaging work was
performed at the Northwestern University Cell Imaging Facility
generously supported by NCI CCSG P30 CA060553 awarded to
the Robert H. Lurie Comprehensive Cancer Center. We would like
to thank Crystle Ashford for technical assistance.
REFERENCES
Bachman, K. E., Rountree, M. R., and Baylin, S. B. (2001). Dnmt3a and Dnmt3b
are transcriptional repressors that exhibit unique localization properties to
heterochromatin. J. Biol. Chem. 276, 32282–32287. doi: 10.1074/jbc.M1046
61200
Baliki, M. N., Geha, P. Y., Fields, H. L., and Apkarian, A. V. (2010). Predicting value
of pain and analgesia: nucleus accumbens response to noxious stimuli changes
in the presence of chronic pain. Neuron 66, 149–160. doi: 10.1016/j.neuron.2010.
03.002
Baliki, M. N., Petre, B., Torbey, S., Herrmann, K. M., Huang, L., Schnitzer, T. J., et al.
(2012). Corticostriatal functional connectivity predicts transition to chronic back
pain. Nat. Neurosci. 15, 1117–1119. doi: 10.1038/nn.3153
Barreto, G., Schafer, A., Marhold, J., Stach, D., Swaminathan, S. K., Handa, V., et al.
(2007). Gadd45a promotes epigenetic gene activation by repair-mediated DNA
demethylation. Nature 445, 671–675. doi: 10.1038/nature05515
Bestor, T., Laudano, A., Mattaliano, R., and Ingram, V. (1988). Cloning and
sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The
carboxyl-terminal domain of the mammalian enzymes is related to bacterial
restriction methyltransferases. J. Mol. Biol. 203, 971–983. doi: 10.1016/0022-
2836(88)90122-2
Bird, G. C., Lash, L. L., Han, J. S., Zou, X., Willis, W. D., and Neugebauer, V.
(2005). Protein kinase A-dependent enhanced NMDA receptor function in pain-
related synaptic plasticity in rat amygdala neurones. J. Physiol. 564, 907–921. doi:
10.1113/jphysiol.2005.084780
Braz, J. M., Sharif-Naeini, R.,Vogt, D., Kriegstein,A., Alvarez-Buylla, A., Rubenstein,
J. L., et al. (2012). Forebrain GABAergic neuron precursors integrate into adult
spinal cord and reduce injury-induced neuropathic pain. Neuron 74, 663–675.
doi: 10.1016/j.neuron.2012.02.033
Bruniquel, D., and Schwartz, R. H. (2003). Selective, stable demethylation of the
interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 4,
235–240. doi: 10.1038/ni887
Bustin, S. A., Beaulieu, J. F., Huggett, J., Jaggi, R., Kibenge, F. S., Olsvik, P. A., et al.
(2010). MIQE precis: practical implementation of minimum standard guidelines
for ﬂuorescence-based quantitative real-time PCR experiments. BMC Mol. Biol.
11:74. doi: 10.1186/1471-2199-11-74
Butler, R., and Bates, G. P. (2006). Histone deacetylase inhibitors as therapeutics for
polyglutamine disorders. Nat. Rev. Neurosci. 7, 784–796. doi: 10.1038/nrn1989
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., and Yaksh, T. L. (1994).
Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods
53, 55–63. doi: 10.1016/0165-0270(94)90144-9
Chedin, F. (2011). The DNMT3 family of mammalian de novo DNA methyl-
transferases. Prog. Mol. Biol. Transl. Sci. 101, 255–285. doi: 10.1016/B978-0-
12-387685-0.00007-X
Costigan, M., Befort, K., Karchewski, L., Grifﬁn, R. S., D’urso, D., Allchorne,
A., et al. (2002). Replicate high-density rat genome oligonucleotide microarrays
reveal hundreds of regulated genes in the dorsal root ganglion after peripheral
nerve injury. BMC Neurosci. 3:16. doi: 10.1186/1471-2202-3-16
Coull, J. A., Boudreau, D., Bachand, K., Prescott, S. A., Nault, F., Sik, A., et al. (2003).
Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism
of neuropathic pain. Nature 424, 938–942. doi: 10.1038/nature01868
Decosterd, I., and Woolf, C. J. (2000). Spared nerve injury: an animal model of
persistent peripheral neuropathic pain. Pain 87, 149–158. doi: 10.1016/S0304-
3959(00)00276-1
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 217 | 8
Pollema-Mays et al. DNMT expression in neuropathic pain
Devor, M., and Wall, P. D. (1990). Cross-excitation in dorsal root ganglia of nerve-
injured and intact rats. J. Neurophysiol. 64, 1733–1746.
Dib-Hajj, S. D., Fjell, J., Cummins, T. R., Zheng, Z., Fried, K., Lamotte, R.,
et al. (1999). Plasticity of sodium channel expression in DRG neurons in the
chronic constriction injury model of neuropathic pain. Pain 83, 591–600. doi:
10.1016/S0304-3959(99)00169-4
Di Giaimo, R., Russo, G. M., Bevilacqua, M. A., Iovine, B., Del Gaudio, R., Geraci,
G., et al. (2005). The expression of de novo DNA methylase DNMT3b, of the
methyl-CpG binding protein MBD2b and of 5-MCDG glycosylase shows two
waves of induction during CaCO-2 cell differentiation. Gene 351, 73–81. doi:
10.1016/j.gene.2005.02.015
Dupont, C., and Gribnau, J. (2013). Different ﬂavors of X-chromosome inactivation
in mammals. Curr. Opin. Cell Biol. 25, 314–321. doi: 10.1016/j.ceb.2013.03.001
Dworkin, R. H. (2002). An overview of neuropathic pain: syndromes, symptoms,
signs, and several mechanisms. Clin. J. Pain 18, 343–349. doi: 10.1097/00002508-
200211000-00001
Ehrlich, M. (2003). Expression of various genes is controlled by DNA methy-
lation during mammalian development. J. Cell. Biochem. 88, 899–910. doi:
10.1002/jcb.10464
Fan, N., Sikand, P., Donnelly, D. F., Ma, C., and Lamotte, R. H. (2011). Increased
Na+ and K+ currents in small mouse dorsal root ganglion neurons after ganglion
compression. J. Neurophysiol. 106, 211–218. doi: 10.1152/jn.00065.2011
Feng, J., Zhou, Y., Campbell, S. L., Le, T., Li, E., Sweatt, J. D., et al. (2010). Dnmt1
and Dnmt3a maintain DNA methylation and regulate synaptic function in adult
forebrain neurons. Nat. Neurosci. 13, 423–430. doi: 10.1038/nn.2514
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., and Tsai, L. H. (2007). Recovery
of learning and memory is associated with chromatin remodelling. Nature 447,
178–182. doi: 10.1038/nature05772
Gardner, E. P., Martin, J. H., and Jessell, T. M. (2000). “The bodily senses,” in
Principles of Neural Science, eds T. M. Jessell, E. R. Kandel, and J. H. Schwartz
(New York: McGraw-Hill).
Gendrel, A. V., Apedaile, A., Coker, H., Termanis, A., Zvetkova, I., Godwin, J., et al.
(2012). Smchd1-dependent and -independent pathways determine developmen-
tal dynamics of CpG island methylation on the inactive X chromosome. Dev. Cell
23, 265–279. doi: 10.1016/j.devcel.2012.06.011
Gopalakrishnan, S., Van Emburgh, B. O., Shan, J., Su, Z., Fields, C. R., Vieweg, J.,
et al. (2009). A novel DNMT3B splice variant expressed in tumor and pluripotent
cells modulates genomic DNA methylation patterns and displays altered DNA
binding. Mol. Cancer Res. 7, 1622–1634. doi: 10.1158/1541-7786.MCR-09-0018
Gordon, C. A., Hartono, S. R., and Chedin, F. (2013). Inactive DNMT3B
splice variants modulate de novo DNA methylation. PLoS ONE 8:e69486. doi:
10.1371/journal.pone.0069486
Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., et al.
(2005). Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad.
Sci. U.S.A. 102, 9341–9346. doi: 10.1073/pnas.0503736102
Jimenez-Andrade, J. M., Peters, C. M., Mejia, N. A., Ghilardi, J. R., Kuskowski, M.
A., and Mantyh, P. W. (2006). Sensory neurons and their supporting cells located
in the trigeminal, thoracic and lumbar ganglia differentially express markers of
injury following intravenous administration of paclitaxel in the rat. Neurosci. Lett.
405, 62–67. doi: 10.1016/j.neulet.2006.06.043
Kaas, G. A., Zhong, C., Eason, D. E., Ross, D. L., Vachhani, R. V., Ming, G. L.,
et al. (2013). TET1 controls CNS 5-methylcytosine hydroxylation, active DNA
demethylation, gene transcription, and memory formation. Neuron 79, 1086–
1093. doi: 10.1016/j.neuron.2013.08.032
Kajander, K. C., Wakisaka, S., and Bennett, G. J. (1992). Spontaneous discharge
originates in the dorsal root ganglion at the onset of a painful peripheral neu-
ropathy in the rat. Neurosci. Lett. 138, 225–228. doi: 10.1016/0304-3940(92)
90920-3
Ko, Y. G., Nishino, K., Hattori, N., Arai, Y., Tanaka, S., and Shiota, K. (2005).
Stage-by-stage change in DNA methylation status of Dnmt1 locus during mouse
early development. J. Biol. Chem. 280, 9627–9634. doi: 10.1074/jbc.M4138
22200
LaPlant, Q., Vialou, V., Covington, H. E. III, Dumitriu, D., Feng, J., Warren, B. L.,
et al. (2010). Dnmt3a regulates emotional behavior and spine plasticity in the
nucleus accumbens. Nat. Neurosci. 13, 1137–1143. doi: 10.1038/nn.2619
Li,X.Y.,Ko,H.G.,Chen,T.,Descalzi,G.,Koga,K.,Wang,H., et al. (2010). Alleviating
neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate
cortex. Science 330, 1400–1404. doi: 10.1126/science.1191792
Lubin, F.D., Roth, T. L., and Sweatt, J. D. (2008). Epigenetic regulation of BDNF gene
transcription in the consolidation of fear memory. J. Neurosci. 28, 10576–10586.
doi: 10.1523/JNEUROSCI.1786-08.2008
Lyko, F., Ramsahoye, B. H., Kashevsky, H., Tudor, M., Mastrangelo, M. A.,
Orr-Weaver,T. L., et al. (1999). Mammalian (cytosine-5)methyltransferases cause
genomic DNA methylation and lethality in Drosophila. Nat. Genet. 23, 363–366.
doi: 10.1038/15551
McGowan, P. O., Sasaki, A., D’alessio, A. C., Dymov, S., Labonte, B., Szyf, M.,
et al. (2009). Epigenetic regulation of the glucocorticoid receptor in human
brain associates with childhood abuse. Nat. Neurosci. 12, 342–348. doi:
10.1038/nn.2270
Metivier, R., Gallais, R., Tiffoche, C., Le Peron, C., Jurkowska, R. Z., Carmouche, R.
P., et al. (2008). Cyclical DNA methylation of a transcriptionally active promoter.
Nature 452, 45–50. doi: 10.1038/nature06544
Metz, A. E., Yau, H. J., Centeno, M. V., Apkarian, A. V., and Martina, M.
(2009). Morphological and functional reorganization of rat medial prefrontal
cortex in neuropathic pain. Proc. Natl. Acad. Sci. U.S.A. 106, 2423–2428. doi:
10.1073/pnas.0809897106
Michaelis, M., Devor, M., and Janig, W. (1996). Sympathetic modulation of activity
in rat dorsal root ganglion neurons changes over time following peripheral nerve
injury. J. Neurophysiol. 76, 753–763.
Miller, C.A.,Gavin,C. F.,White, J.A., Parrish, R. R.,Honasoge,A.,Yancey,C. R., et al.
(2010). Cortical DNA methylation maintains remote memory. Nat. Neurosci. 13,
664–666. doi: 10.1038/nn.2560
Miller, C. A., and Sweatt, J. D. (2007). Covalent modiﬁcation of DNA regulates
memory formation. Neuron 53, 857–869. doi: 10.1016/j.neuron.2007.02.022
Mutso, A. A., Radzicki, D., Baliki, M. N., Huang, L., Banisadr, G., Centeno, M. V.,
et al. (2012). Abnormalities in hippocampal functioning with persistent pain. J.
Neurosci. 32, 5747–5756. doi: 10.1523/JNEUROSCI.0587-12.2012
Neugebauer, V., and Li, W. (2003). Differential sensitization of amygdala neurons
to afferent inputs in a model of arthritic pain. J. Neurophysiol. 89, 716–727. doi:
10.1152/jn.00799.2002
Neugebauer, V., Li, W., Bird, G. C., Bhave, G., and Gereau, R. W. T. (2003). Synap-
tic plasticity in the amygdala in a model of arthritic pain: differential roles of
metabotropic glutamate receptors 1 and 5. J. Neurosci. 23, 52–63.
Nordin, M., Nystrom, B., Wallin, U., and Hagbarth, K. E. (1984). Ectopic sen-
sory discharges and paresthesiae in patients with disorders of peripheral nerves,
dorsal roots and dorsal columns. Pain 20, 231–245. doi: 10.1016/0304-3959(84)
90013-7
Novakovic, S. D., Tzoumaka, E., Mcgivern, J. G., Haraguchi, M., Sangameswaran,
L., Gogas, K. R., et al. (1998). Distribution of the tetrodotoxin-resistant sodium
channel PN3 in rat sensory neurons in normal and neuropathic conditions. J.
Neurosci. 18, 2174–2187.
Okano, M., Bell, D. W., Haber, D. A., and Li, E. (1999). DNA methyltransferases
Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian
development. Cell 99, 247–257. doi: 10.1016/S0092-8674(00)81656-6
Okano, M., Xie, S., and Li, E. (1998). Cloning and characterization of a family of
novelmammalianDNA(cytosine-5)methyltransferases. Nat. Genet. 19, 219–220.
doi: 10.1038/890
Ooi, S. K., and Bestor, T. H. (2008). The colorful history of active DNA
demethylation. Cell 133, 1145–1148. doi: 10.1016/j.cell.2008.06.009
Ooi, S. K., Wolf, D., Hartung, O., Agarwal, S., Daley, G. Q., Goff, S. P., et al. (2010).
Dynamic instability of genomic methylation patterns in pluripotent stem cells.
Epigenetics Chromatin 3, 17. doi: 10.1186/1756-8935-3-17
Ostler, K. R., Davis, E. M., Payne, S. L., Gosalia, B. B., Exposito-Cespedes, J., Le
Beau, M. M., et al. (2007). Cancer cells express aberrant DNMT3B transcripts
encoding truncated proteins. Oncogene 26, 5553–5563. doi: 10.1038/sj.onc.
1210351
Qin, W., Leonhardt, H., and Pichler, G. (2011). Regulation of DNA methyl-
transferase 1 by interactions and modiﬁcations. Nucleus 2, 392–402. doi:
10.4161/nucl.2.5.17928
Ren, W. J., Liu, Y., Zhou, L. J., Li, W., Zhong, Y., Pang, R. P., et al. (2011). Peripheral
nerve injury leads to working memory deﬁcits and dysfunction of the hippocam-
pus by upregulation of TNF-α in rodents. Neuropsychopharmacology 36, 979–992.
doi: 10.1038/npp.2010.236
Ringkamp, M., and Meyer, R. A. (2009). “Physiology of nociceptors,” in Science
of Pain, eds M. C. Bushnell and A. I. Bausbaum (San Diego: Academic Press),
97–114.
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 217 | 9
Pollema-Mays et al. DNMT expression in neuropathic pain
Rountree, M. R., Bachman, K. E., and Baylin, S. B. (2000). DNMT1 binds HDAC2
and a new co-repressor, DMAP1, to form a complex at replication foci. Nat.
Genet. 25, 269–277. doi: 10.1038/77023
Schmittgen, T. D., and Livak, K. J. (2008). Analyzing real-time PCR data by
the comparative C(T) method. Nat. Protoc. 3, 1101–1108. doi: 10.1038/nprot.
2008.73
Sharif, J., Muto, M., Takebayashi, S., Suetake, I., Iwamatsu, A., Endo, T. A.,
et al. (2007). The SRA protein Np95 mediates epigenetic inheritance by recruit-
ing Dnmt1 to methylated DNA. Nature 450, 908–912. doi: 10.1038/nature
06397
Sharma, R. P., Tun, N., and Grayson, D. R. (2008). Depolarization induces down-
regulation of DNMT1 and DNMT3a in primary cortical cultures. Epigenetics 3,
74–80. doi: 10.4161/epi.3.2.6103
Sukhotinsky, I., Ben-Dor, E., Raber, P., and Devor, M. (2004). Key role of the dorsal
root ganglion in neuropathic tactile hypersensibility. Eur. J. Pain 8, 135–143. doi:
10.1016/S1090-3801(03)00086-7
Szyf, M., and Bick, J. (2013). DNA methylation: a mechanism for embedding
early life experiences in the genome. Child Dev. 84, 49–57. doi: 10.1111/j.1467-
8624.2012.01793.x
Tan, Z. Y., Donnelly, D. F., and Lamotte, R. H. (2006). Effects of a chronic
compression of the dorsal root ganglion on voltage-gated Na+ and K+ cur-
rents in cutaneous afferent neurons. J. Neurophysiol. 95, 1115–1123. doi:
10.1152/jn.00830.2005
Tanaka, M., Cummins, T. R., Ishikawa, K., Dib-Hajj, S. D., Black, J. A., and Waxman,
S. G. (1998). SNS Na+ channel expression increases in dorsal root ganglion
neurons in the carrageenan inﬂammatory pain model. Neuroreport 9, 967–972.
doi: 10.1097/00001756-199804200-00003
Tochiki, K. K., Cunningham, J., Hunt, S. P., and Geranton, S. M. (2012). The
expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases
and histone deacetylases is modulated in persistent pain states. Mol. Pain 8, 14.
doi: 10.1186/1744-8069-8-14
Tremolizzo, L., Carboni, G., Ruzicka, W. B., Mitchell, C. P., Sugaya, I., Tueting,
P., et al. (2002). An epigenetic mouse model for molecular and behavioral neu-
ropathologies related to schizophrenia vulnerability. Proc. Natl. Acad. Sci. U.S.A.
99, 17095–17100. doi: 10.1073/pnas.262658999
Uchida, H., Ma, L., and Ueda, H. (2010a). Epigenetic gene silencing under-
lies C-ﬁber dysfunctions in neuropathic pain. J. Neurosci. 30, 4806–4814. doi:
10.1523/JNEUROSCI.5541-09.2010
Uchida, H., Sasaki, K., Ma, L., and Ueda, H. (2010b). Neuron-restrictive silencer
factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury.
Neuroscience 166, 1–4. doi: 10.1016/j.neuroscience.2009.12.021
Veldic, M., Guidotti, A., Maloku, E., Davis, J. M., and Costa, E. (2005). In psychosis,
cortical interneurons overexpress DNA-methyltransferase 1. Proc. Natl. Acad. Sci.
U.S.A. 102, 2152–2157. doi: 10.1073/pnas.0409665102
Wang, J., Walsh, G., Liu, D. D., Lee, J. J., and Mao, L. (2006a). Expression of Delta
DNMT3B variants and its association with promoter methylation of p16 and
RASSF1A in primary non-small cell lung cancer. Cancer Res. 66, 8361–8366. doi:
10.1158/0008-5472.CAN-06-2031
Wang, L., Wang, J., Sun, S., Rodriguez, M., Yue, P., Jang, S. J., et al. (2006b). A novel
DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in
non-small cell lung cancer. Int. J. Oncol. 29, 201–207.
Wang, Y., Liu, C., Guo, Q. L., Yan, J. Q., Zhu, X. Y., Huang, C. S.,
et al. (2011). Intrathecal 5-azacytidine inhibits global DNA methylation and
methyl- CpG-binding protein 2 expression and alleviates neuropathic pain
in rats following chronic constriction injury. Brain Res. 1418, 64–69. doi:
10.1016/j.brainres.2011.08.040
Weng, X., Smith, T., Sathish, J., and Djouhri, L. (2012). Chronic inﬂammatory
pain is associated with increased excitability and hyperpolarization-activated
current (Ih) in C- but not Adelta-nociceptors. Pain 153, 900–914. doi:
10.1016/j.pain.2012.01.019
Wolf, S. F., Jolly, D. J., Lunnen, K. D., Friedmann, T., and Migeon, B. R. (1984).
Methylation of the hypoxanthine phosphoribosyltransferase locus on the human
X chromosome: implications for X-chromosome inactivation. Proc. Natl. Acad.
Sci. U.S.A. 81, 2806–2810. doi: 10.1073/pnas.81.9.2806
Wolffe, A. P., and Matzke, M. A. (1999). Epigenetics: regulation through repression.
Science 286, 481–486. doi: 10.1126/science.286.5439.481
Xiang, Z., Xiong, Y., Yan, N., Li, X., Mao, Y., Ni, X., et al. (2008). Func-
tional up-regulation of P2X3 receptors in the chronically compressed dorsal root
ganglion. Pain 140, 23–34. doi: 10.1016/j.pain.2008.07.006
Xiao, H. S., Huang, Q. H., Zhang, F. X., Bao, L., Lu, Y. J., Guo, C., et al. (2002). Iden-
tiﬁcation of gene expression proﬁle of dorsal root ganglion in the rat peripheral
axotomy model of neuropathic pain. Proc. Natl. Acad. Sci. U.S.A. 99, 8360–8365.
doi: 10.1073/pnas.122231899
Xie, S., Wang, Z., Okano, M., Nogami, M., Li, Y., He, W. W., et al. (1999). Cloning,
expression and chromosome locations of the human DNMT3 gene family. Gene
236, 87–95. doi: 10.1016/S0378-1119(99)00252-8
Zhang, L., Lu, D. Y., Ma, W. Y., and Li, Y. (2011a). Age-related changes in the
localization of DNA methyltransferases during meiotic maturation in mouse
oocytes. Fertil. Steril. 95, 1531–1534 e1. doi: 10.1016/j.fertnstert.2010.06.050
Zhang, Z., Cai, Y. Q., Zou, F., Bie, B., and Pan, Z. Z. (2011b). Epigenetic suppression
of GAD65 expression mediates persistent pain. Nat. Med. 17, 1448–1455. doi:
10.1038/nm.2442
Zhu, Q., Wang, L., Zhang, Y., Zhao, F. H., Luo, J., Xiao, Z., et al. (2012). Increased
expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy.
J. Mol. Neurosci. 46, 420–426. doi: 10.1007/s12031-011-9602-7
Conflict of Interest Statement:The authors declare that the research was conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 18 January 2014; accepted: 17 July 2014; published online: 08 August 2014.
Citation: Pollema-Mays SL, Centeno MV,Apkarian AV and Martina M (2014) Expres-
sion of DNA methyltransferases in adult dorsal root ganglia is cell-type speciﬁc and up
regulated in a rodent model of neuropathic pain. Front. Cell. Neurosci. 8:217. doi:
10.3389/fncel.2014.00217
This article was submitted to the journal Frontiers in Cellular Neuroscience.
Copyright © 2014 Pollema-Mays, Centeno, Apkarian and Martina. This is an open-
access article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Cellular Neuroscience www.frontiersin.org August 2014 | Volume 8 | Article 217 | 10
